Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Midge Medical GmbH has 2 pending office actions in Biotechnology & Pharmaceuticals. Both matters are assigned to 1 distinct examiner and 1 distinct art unit, so the pending activity is concentrated within one examination channel.
SWITZER, JULIET CAROLINE is the busiest examiner, with 2 pending matters. The examiner therefore handles the complete pending workload shown. A coordinated response approach may help maintain consistent technical positions and claim terminology across the two matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SWITZER, JULIET CAROLINE | 1 | 42.4% | +54.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18548619 | PROTECTED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (PINA) METHODS FOR POINT-OF-NEED DIAGNOSIS OF EMERGING INFECTIOUS DISEASES | SWITZER, JULIET CAROLINE | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18548619 | PROTECTED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (PINA) METHODS FOR POINT-OF-NEED DIAGNOSIS OF EMERGING INFECTIOUS DISEASES | SWITZER, JULIET CAROLINE | 1682 | §102§103§112DP | Non-Final OA | — | Pending | Sep 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialMidge Medical GmbH has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Juliet Caroline Switzer has the most, with 1 of Midge Medical GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
